指南与共识男科与性医学

欧洲泌尿外科学会男性性健康与生殖健康指南:2025年男性不育更新

European Association of Urology Guidelines on Male Sexual and Reproductive Health: 2025 Update on Male Infertility.
指南 / 共识 · Eur Urol · 2025-03-20

本文总结了2025年欧洲泌尿外科学会(EAU)性健康与生殖健康(SRH)指南中男性不育部分的更新,涵盖诊断、治疗与随访的实用推荐。指南基于Medline、EMBASE和Cochrane图书馆的结构化文献评估制定推荐,强调对不育男性进行全面泌尿系统评估、平行评估女性伴侣以及就相关健康风险提供咨询。2025年关键变化包括新增外显子组测序和益生菌治疗两个章节,并大幅更新男性不育诊断检查的证据基础与推荐。

要点

  • 所有因生育问题就诊的男性均应接受全面泌尿系统评估以确保适当治疗。
  • 不育夫妇诊治过程中应平行评估女性伴侣,以促进时机和治疗策略的共同决策。
  • 推荐就相关健康风险向所有不育男性和精液参数异常男性提供咨询。

核心结论

  • 2025年SRH指南概述为男性因素不育的诊断、分类、治疗和随访提供了有价值的见解,旨在有效整合到临床实践中。

研究设计与样本

  • 2025年SRH指南通过结构化文献评估识别、整理和评价新的相关证据,检索数据库包括Medline、EMBASE和Cochrane图书馆。
  • 指南推荐由专家组制定,以优先考虑临床重要的诊疗决策;每条推荐的强度根据替代管理策略的利弊平衡、证据质量(包括估计的确定性)以及患者价值观和偏好的性质与变异性确定。

主要发现

  • 关键推荐强调对所有因生育问题就医的男性进行彻底泌尿系统评估以确保适当治疗的重要性。
  • 指南强调在不育夫妇诊断和管理过程中平行调查女性伴侣的临床相关性,以促进时机和治疗策略的共同决策。
  • 指南推荐就相关健康风险向所有不育男性和精液参数异常男性提供咨询。
  • 2025年男性不育指南的关键变化包括新增外显子组测序和益生菌治疗两个章节,以及大幅更新男性不育诊断检查的证据基础与推荐。

临床怎么用

  • 对所有因生育问题就诊的男性进行彻底泌尿系统评估以确保适当治疗。
  • 在不育夫妇诊断和管理过程中平行调查女性伴侣,以促进时机和治疗策略的共同决策。
  • 就相关健康风险向所有不育男性和精液参数异常男性提供咨询。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVE: To present a summary of the updated 2025 European Association of Urology (EAU) Guidelines on Sexual and Reproductive Health (SRH) on male infertility, providing practical recommendations on the clinical work-up with a focus on diagnosis, treatment and follow-up. METHODS: For the 2025 SRH guidelines, new and relevant evidence was identified, collated, and appraised via a structured assessment of the literature. Databases searched included Medline, EMBASE, and the Cochrane Libraries. Recommendations within the guidelines were developed by the panel to prioritise clinically important care decisions. The strength of each recommendation was determined according to a balance between desirable and undesirable consequences of alternative management strategies, the quality of the evidence (including the certainty of estimates), and the nature and variability of patient values and preferences. KEY FINDINGS AND LIMITATIONS: Key recommendations emphasise the importance of a thorough urological assessment of all men seeking medical help for fertility problems to ensure appropriate treatment. The guidelines also stress the clinical relevance of a parallel investigation of the female partner during the diagnostic and management work-up of the infertile couple, to promote shared-decision making in terms of timing and therapeutic strategies. Furthermore, the guidelines recommend to counsel all infertile men and men with abnormal semen parameters on the associated health risks. Key changes in the male infertility guidelines for 2025 include: the addition of two new sections addressing exome sequencing and probiotic treatment; and significant update of the evidence base and recommendations for the diagnostic work-up of male infertility. CONCLUSIONS AND CLINICAL IMPLICATIONS: This overview of the 2025 SHR guidelines offers valuable insights into the diagnosis, classification, treatment and follow-up of male factor infertility and are designed for effective integration into clinical practice.

来源:Eur Urol,查看原文。版权归原作者所有。

引用

  1. Minhas S, Boeri L, Capogrosso P, et al. European Association of Urology Guidelines on Male Sexual and Reproductive Health: 2025 Update on Male Infertility. Eur Urol. 2025. PMID: 40118737. doi:10.1016/j.eururo.2025.02.026

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。